A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.


Journal

Journal of autoimmunity
ISSN: 1095-9157
Titre abrégé: J Autoimmun
Pays: England
ID NLM: 8812164

Informations de publication

Date de publication:
07 2019
Historique:
received: 19 02 2019
revised: 08 04 2019
accepted: 08 04 2019
pubmed: 3 5 2019
medline: 21 7 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Alteration in endogenous Interferon (IFN) system may profoundly impact immune cell function in autoimmune diseases. Here, we provide evidence that dysregulation in IFN-regulated genes and pathways are involved in B cell- and monocyte-driven pathogenic contribution to Multiple Sclerosis (MS) development and maintenance. In particular, by using an Interferome-based cell type-specific approach, we characterized an increased susceptibility to an IFN-linked caspase-3 dependent apoptotic cell death in both B cells and monocytes of MS patients that may arise from their chronic activation and persistent stimulation by activated T cells. Ongoing caspase-3 activation functionally impacts on MS monocyte properties influencing the STAT-3/IL-16 axis, thus, driving increased expression and massive release of the bio-active IL-16 triggering and perpetuating CD4

Identifiants

pubmed: 31047767
pii: S0896-8411(19)30094-0
doi: 10.1016/j.jaut.2019.04.006
pii:
doi:

Substances chimiques

Biomarkers 0
Interferon Type I 0
Interleukin-16 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-16

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Martina Severa (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: martina.severa@iss.it.

Fabiana Rizzo (F)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Sundararajan Srinivasan (S)

Institute of Experimental Neurology (INSpe), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Marco Di Dario (M)

Institute of Experimental Neurology (INSpe), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Elena Giacomini (E)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Maria Chiara Buscarinu (MC)

Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, Rome, Italy.

Melania Cruciani (M)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Marilena P Etna (MP)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Silvia Sandini (S)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Rosella Mechelli (R)

Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, Rome, Italy; Department of Human Science and Promotion of Quality of Life, San Raffaele Roma Open University and IRCCS San Raffaele-Pisana, Rome, Italy.

Antonella Farina (A)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Pankaj Trivedi (P)

Department of Experimental Medicine, Sapienza University, Rome, Italy.

Paul J Hertzog (PJ)

Department of Molecular and Translational Sciences, Monash University, Clayton, Australia.

Marco Salvetti (M)

Center for Experimental Neurological Therapies, Sant'Andrea Hospital, Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, Rome, Italy; Istituto Neurologico Mediterraneo (INM) Neuromed, Pozzilli, Isernia, Italy.

Cinthia Farina (C)

Institute of Experimental Neurology (INSpe), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Eliana M Coccia (EM)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: eliana.coccia@iss.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH